RDY 310 (Nizatidine 150 mg)

Pill imprint RDY 310 has been identified as Nizatidine 150 mg.

Nizatidine is used in the treatment of gerd; erosive esophagitis; indigestion; duodenal ulcer prophylaxis; stomach ulcer (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Nizatidine 150 mg is not a controlled substance under the Controlled Substance Act (CSA).

Nizatidine

Imprint:

RDY 310

Strength:

150 mg

Color:

Pink & Yellow

Size:

18.00 mm

Shape:

Capsule-shape

Availability:

Rx and/or OTC

Drug Class:

H2 antagonists

Pregnancy Category:

B - No proven risk in humans

CSA Schedule:

Not a controlled drug

Manufacturer:

Dr. Reddy’s Laboratories Inc.

National Drug Code (NDC):

55111-0310

Inactive Ingredients:

croscarmellose sodium
povidone
corn starch
dimethicone
magnesium silicate
D&C Yellow No. 10
titanium dioxide
gelatin
D&C Red No. 28
FD&C Blue No. 1
FD&C Red No. 40
shellac
ferric oxide black
butyl alcohol
propylene glycol
FD&C Blue No. 2
ethyl alcohol

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.